0001213900-23-098486.txt : 20231226 0001213900-23-098486.hdr.sgml : 20231226 20231226130418 ACCESSION NUMBER: 0001213900-23-098486 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20231223 FILED AS OF DATE: 20231226 DATE AS OF CHANGE: 20231226 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: HULL ANDREW CENTRAL INDEX KEY: 0001818252 ORGANIZATION NAME: FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-39685 FILM NUMBER: 231512385 MAIL ADDRESS: STREET 1: C/O INMED PHARMACEUTICALS INC. STREET 2: SUITE 310 - 815 HASTINGS STREET CITY: VANCOUVER STATE: A1 ZIP: V6C 1B4 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: InMed Pharmaceuticals Inc. CENTRAL INDEX KEY: 0001728328 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] ORGANIZATION NAME: 03 Life Sciences IRS NUMBER: 000000000 STATE OF INCORPORATION: A1 FISCAL YEAR END: 0630 BUSINESS ADDRESS: STREET 1: SUITE 310, 815 W. HASTINGS STREET CITY: VANCOUVER STATE: A1 ZIP: V6C 1B4 BUSINESS PHONE: (604) 669-7207 MAIL ADDRESS: STREET 1: SUITE 310, 815 W. HASTINGS STREET CITY: VANCOUVER STATE: A1 ZIP: V6C 1B4 4 1 ownership.xml X0508 4 2023-12-23 0 0001728328 InMed Pharmaceuticals Inc. INM 0001818252 HULL ANDREW C/O INMED PHARMACEUTICALS INC. 310-815 WEST HASTINGS ST. VANCOUVER A1 V6C1B4 BRITISH COLUMBIA, CANADA 1 0 0 0 0 Employee Stock Option (Right to Buy) 0.37 2023-12-23 4 A 0 7100 0.00 A 2028-12-22 Common shares 7100 8584 D The options were granted on 12/23/2023 and will vest 100% on the one-year anniversary of the grant date (December 23, 2024) or immediately prior to the next Annual General Meeting, whichever is sooner. /s/ Eric A Adams, attorney-in-fact for Mr. Andrew Hull 2023-12-26